{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T14:10:26Z","timestamp":1732025426256,"version":"3.28.0"},"reference-count":61,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/13543784.2024.2388565","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T07:55:23Z","timestamp":1722844523000},"page":"939-944","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment"],"prefix":"10.1080","volume":"33","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Focosi","sequence":"additional","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,11]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-24"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13405-8"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106073442307"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.2450\/2007.0024-07"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1605567"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01123-X"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-195313"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2450\/2016.0158-16"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12133"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12470"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2196012"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2014.947955"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.946010"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.721780"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.03.016"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17580"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S252580"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32722-7"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000969"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12270"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-872291"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01868-7"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305074"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30193-4"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004085"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14036"},{"key":"e_1_3_4_30_1","unstructured":"European Medicines Agency. ALPROLIX (eftrenonacog alfa): EU public assessment report. 2016 [cited 2024 Feb 22]. Available from: http:\/\/www.ema.europa.eu\/"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336172"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-335596"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12000"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-573055"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13041"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.02.030"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1709521"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12412"},{"key":"e_1_3_4_39_1","unstructured":"European Medicines Agency. Refixia (nonacog beta pegol). [cited 2024 Feb 22]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/refixia"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-04-0255"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-669234"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-03-0179"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14778"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1705116"},{"key":"e_1_3_4_45_1","unstructured":"European Medicines Agency. Idelvion. Idelvion | European medicines agency (europa.Eu). [cited 2024 Feb 22]."},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13590"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240896"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1389.1389"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15259"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14315"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02570-6"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14531"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26018"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2184341"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904377"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3757.3757"},{"issue":"1","key":"e_1_3_4_57_1","first-page":"98","article-title":"The pharmacokinetic profiles of intravenously and subcutaneously administered recombinant factor IX fc-xten in cynomolgus monkeys","volume":"1","author":"Van der Flier A","year":"2017","unstructured":"Van der Flier A, Ismail A, Moore N, et al. The pharmacokinetic profiles of intravenously and subcutaneously administered recombinant factor IX fc-xten in cynomolgus monkeys. Res Pract Theromb Haemost. 2017;1(Suppl. 1):98.","journal-title":"Res Pract Theromb Haemost"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17559"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.11.009"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/pbi.13608"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756188"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2276206"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14907"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2388565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T13:37:28Z","timestamp":1732023448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2388565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/13543784.2024.2388565"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2388565","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"type":"print","value":"1354-3784"},{"type":"electronic","value":"1744-7658"}],"subject":[],"published":{"date-parts":[[2024,8,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}